Protherics PLC 6 monthly Block Listing Return Individual Unapproved Share Options London, UK; Brentwood, TN; 9 October 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, in accordance with Listing Rule 3.5.6, notifies the following details in respect of the block listing for its Individual Unapproved share option arrangements: Name of applicant: Protherics PLC Name of scheme: Individual Unapproved share option arrangements Period of return: From: 9 April To: 8 2008 October 2008 Balance of unallotted securities under 640,000 scheme at beginning of period: The amount by which the block scheme has Nil been increased during the period: Number of securities issued/allotted under Nil scheme during period: Balance under scheme not yet issued/ 640,000 allotted at end of period / Ends / For further information please contact: Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518010 Financial Dynamics - press enquiries London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113 New York: John Capodanno +1 212 850 5600 Or visit www.protherics.com This information is provided by RNS The company news service from the London Stock Exchange END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com